•
Sep 30, 2017

Outlook Therapeutics Q4 2017 Earnings Report

Total Revenue
$2.9M
Previous year: $495K
+486.4%
EPS
-$6.2
Previous year: -$4.8
+29.2%
Gross Profit
$0
0
Cash and Equivalents
$3.19M
Previous year: $2.35M
+35.4%
Free Cash Flow
$55.9K
Total Assets
$20.7M
Previous year: $25.4M
-18.4%

Outlook Therapeutics

Outlook Therapeutics